Hungary Clinical Oncology NGS Market (2025-2031) | Growth, Size & Revenue, Trends, Forecast, Share, Segmentation, Industry, Outlook, Companies, Value, Competitive Landscape, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Hungary Country Macro Economic Indicators

3.2 Hungary Clinical Oncology NGS Market Revenues & Volume, 2021 & 2031F

3.3 Hungary Clinical Oncology NGS Market - Industry Life Cycle

3.4 Hungary Clinical Oncology NGS Market - Porter's Five Forces

3.5 Hungary Clinical Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 Hungary Clinical Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.7 Hungary Clinical Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F

3.8 Hungary Clinical Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer cases in Hungary

4.2.2 Growing demand for personalized medicine in oncology

4.2.3 Technological advancements in next-generation sequencing (NGS) for clinical oncology

4.3 Market Restraints

4.3.1 High cost associated with NGS technology and testing

4.3.2 Limited reimbursement policies for NGS-based oncology tests in Hungary

6.1 Hungary Clinical Oncology NGS Market, By Technology

6.1.1 Overview and Analysis

6.1.2 Hungary Clinical Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 Hungary Clinical Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.1.4 Hungary Clinical Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.1.5 Hungary Clinical Oncology NGS Market Revenues & Volume, By Targeted Sequencing & Resequencing Centrifuges, 2021- 2031F

6.2 Hungary Clinical Oncology NGS Market, By Workflow

6.2.1 Overview and Analysis

6.2.2 Hungary Clinical Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.2.3 Hungary Clinical Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F

6.2.4 Hungary Clinical Oncology NGS Market Revenues & Volume, By Data Analysis, 2021- 2031F

6.3 Hungary Clinical Oncology NGS Market, By Application

6.3.1 Overview and Analysis

6.3.2 Hungary Clinical Oncology NGS Market Revenues & Volume, By Screening, 2021- 2031F

6.3.3 Hungary Clinical Oncology NGS Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F

6.3.4 Hungary Clinical Oncology NGS Market Revenues & Volume, By Other Diagnostics, 2021- 2031F

6.4 Hungary Clinical Oncology NGS Market, By End-use

6.4.1 Overview and Analysis

6.4.2 Hungary Clinical Oncology NGS Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Hungary Clinical Oncology NGS Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 Hungary Clinical Oncology NGS Market Revenues & Volume, By Laboratories, 2021- 2031F

7.1 Hungary Clinical Oncology NGS Market Export to Major Countries

7.2 Hungary Clinical Oncology NGS Market Imports from Major Countries

8.1 Adoption rate of NGS technology in clinical oncology practices in Hungary

8.2 Number of clinical trials utilizing NGS technology for oncology research

8.3 Rate of integration of NGS-based treatment strategies in oncology care in Hungary

9.1 Hungary Clinical Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 Hungary Clinical Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.3 Hungary Clinical Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F

9.4 Hungary Clinical Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 Hungary Clinical Oncology NGS Market Revenue Share, By Companies, 2024

10.2 Hungary Clinical Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters